Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 144-153 , June 2007

Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy

  • Yangde Zhang, MD, PhD

      Affiliations

    • National Hepatobiliary and Enteric Surgery Research Center, Central South University, Changsha, Hunan, China
    • The first two authors contributed equally to this article.
    • ,
  • Yanqiong Zhang, MD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • The first two authors contributed equally to this article.
    • ,
  • Jiji Chen, MD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • ,
  • Binghua Zhang, MD

      Affiliations

    • Department of Microbiology, Xinjiang Medical University, Urumqi, China
    • ,
  • Yifeng Pan, PhD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • ,
  • Lifeng Ren, MD

      Affiliations

    • Biomedical Engineering Institute of Central South University, Changsha, Hunan, China
    • ,
  • Jinfen Zhao, PhD

      Affiliations

    • National Hepatobiliary and Enteric Surgery Research Center, Central South University, Changsha, Hunan, China
    • ,
  • Yulin Luo, PhD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • ,
  • Denggao Zhai, PhD

      Affiliations

    • National Hepatobiliary and Enteric Surgery Research Center, Central South University, Changsha, Hunan, China
    • ,
  • Shunwei Wang, PhD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • ,
  • Jiwei Wang, PhD

      Affiliations

    • National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan, China
    • Corresponding Author InformationCorresponding author. National Key Laboratory of Nanobiological Technology, Ministry of Health, Changsha, Hunan 410008, China.

Received 22 March 2006 ,Accepted 27 January 2007.

References 

  1. Stefani AL, Barzon L, Castagliuolo I, Guido M, Pacenti M, Pavolin C. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma. J Hepatol. 2005;42(5):728–735
  2. Hattori Y, Maitani Y. Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr Drug Deliv. 2005;2(3):243–252
  3. Cohen H, Levy RJ, Cao J, Gao J, Fishbein I, Kousae V, et al. Sustained delivery and expression of DNA encapsulation in polymeric nanoparticles [J]. Gene Ther. 2000;7:1896–1903
  4. Jacobs AH, Winkler A, Castro MG, Lowentein P. Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging. 2005;32(Suppl):S358–S383
  5. Winn SR, Hu Y, Sfeir C, Hollinger Jo. Gene therapy approaches for modulating bone regeneration [J]. Adv Drug Delivery Rev. 2000;42:121–138
  6. Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol. 2002;21(12):895–913
  7. Hattori Y, Maitani Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther. 2005;12(10):796–809
  8. Guo W, Gosselin MA, Lee RJ. Characterization of a novel diolein-based LPDII vector for gene delivery. J Control Release. 2002;83(1):121–132
  9. Zhang Yangde SY. Construction of eukaryotic expression plasmid carrying HSV-TK gene and its expression in HepG2 cells. China J Mod Med. 2003;13:6–12
  10. Prabha S, Zhou WZ, Panyam J, Labhasewar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm. 2002;244(1-2):105–115
  11. Liu T, Tang A, Zhang G, Chen Y, Zhang J, Peng S, et al. Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy. Cancer Biother Radiopharm. 2005;20(2):141–149
  12. Truter EJ, Santos AS, Els WJ. Assessment of the antitumor activity of targeted immunospecific albumin microspheres loaded with cisplatin and 5-fluorouracil: toxicity against a rodent ovarian carcinoma in vitro. Cell Biol Int. 2001;25:51–59
  13. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318
  14. Li YH, Fan MW, Bian Z, Chen Z, Zhang R, Yang HR. Chitosan-DNA microparticles as mucosal delivery system: synthesis, characterization and release in vitro. Chin Med J. 2005;118(11):936–941
  15. Park IK, Kim TH, Kim SI, Park YH, Kim WJ, Akaike T. Visualization of transfection of hepatocytes by galactosylated chitosan-graft-poly(ethylene glycol)/DNA complexes by confocal laser scanning microscopy. Int J Pharm. 2003;257(1-2):103–110
  16. Bootz A, Russ T, Gores F, Kara M, Kreuter J. Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Eur J Pharm Biopharm. 2005;60(3):391–399
  17. Van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF, Hospers GA. Influence of the bystander effect on HSV-TK/GCV gene therapy. Curr Gene Ther. 2002;3:307–322
  18. Hay MP, Anderson RF, Ferry DM, Wilson UR, Denny WA. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. J Med Chem. 2003;46(25):5533–5545
  19. Germain E, Roullin VG, Qiao J, de Campos Lima PO, Caruso M. RD114-pseudotyped retroviral vectors kill cancer cells by syncytium formation and enhance the cytotoxic effect of the TK/GCV gene therapy strategy. J Gene Med. 2005;7(4):389–397
  20. Kuo YC. Loading efficiency of stavudine on poly-butylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int J Pharm. 2005;290(1-2):161–172
  21. Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol. 2002;21(12):895–913
  22. Fox JL. Gene therapy safety issues come to fore. Nat Biotechnol. 1999;17(12):1153
  23. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300(5626):1749–1751
  24. Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, Grossman SR. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol. 2006;26(6):2360–2372
  25. Menendez D, Inga A, Resnick MA. The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol Cell Biol. 2006;26(6):2297–2308
  26. Lien YC, Lin SM, Nithipongvanitch R, Oberley TD, Noel T, Zhao R, et al. Tumor necrosis factor receptor deficiency exacerbated adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol Cancer Ther. 2006;5(2):261–269

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00042-1

doi: 10.1016/j.nano.2007.01.004

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2 , Pages 144-153 , June 2007

Article Tools

* Image Usage & Resolution